NeoGenomics

Yahoo Finance • 2 months ago

Global Undervalued Small Caps With Insider Action October 2025

In October 2025, global markets are navigating a complex landscape with U.S. stocks advancing despite volatile trade headlines and rising oil prices, while small-cap indices like the Russell 2000 and S&P MidCap 400 have notably outperforme... Full story

Yahoo Finance • 2 months ago

NeoGenomics Q3 2025 Earnings Preview

* NeoGenomics (NASDAQ:NEO [https://seekingalpha.com/symbol/NEO]) is scheduled to announce Q3 earnings results on Tuesday, October 28th, before market open. * The consensus EPS Estimate is $0.02 [https://seekingalpha.com/symbol/NEO/earn... Full story

Yahoo Finance • 3 months ago

agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations. The pharmaceutical and b... Full story

Yahoo Finance • 3 months ago

NEO Battery Closes Upsized Non-Brokered Private Placement Offering of $5.5 Million

TORONTO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (“NEO” or the “Company”) (TSXV: NBM) (OTC: NBMFF), a low-cost, silicon-enhanced battery developer that enables longer-running, rapid-charging batteries for drones, ro... Full story

Yahoo Finance • 3 months ago

Here’s Alger Weatherbie Specialized Growth Fund’s Comment on NeoGenomics (NEO)

Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. Initial volatility in April stemmed from inc... Full story

Yahoo Finance • 3 months ago

NEO Battery Enters into LOI for Operational Battery Component Manufacturing Facility Lease and Announces Non-Brokered Private Placement Offering

TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (“NEO” or the “Company”) (TSXV: NBM) (OTC: NBMFF), a low-cost, silicon-enhanced battery developer that enables longer-running, rapid-charging batteries for drones, ro... Full story

Yahoo Finance • 4 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO).  Such investors are advised to contact Danielle Peyton at new... Full story

Yahoo Finance • 4 months ago

NeoGenomics Gains 'Unexpected' Win As Court Rejects Natera Claims

On Friday, the District Court for the Middle District of North Carolina issued a ruling invalidating specific claims in two patents that Natera Inc. (NASDAQ:NTRA) asserted against NeoGenomics, Inc.'s (NASDAQ:NEO) v1.1 RaDaR test. Natera s... Full story

Yahoo Finance • 4 months ago

Stocks making the biggest moves midday: Petco Health, Celsius, Affirm, Caterpillar & more

Check out the companies making the biggest moves midday: Petco Health & Wellness — The pet store and veterinary services provider surged 22% after raising its full-year adjusted EBITDA guidance. Second-quarter earnings per share topped ana... Full story

Yahoo Finance • 4 months ago

NeoGenomics rallies after court win in Natera patent dispute

[Legal rights concept Statue of Lady Justice holding scales of justice] deepblue4you * NeoGenomics (NASDAQ:NEO [https://seekingalpha.com/symbol/NEO]) shares climbed ~20% in the premarket on Friday after the company announced a major vic... Full story

Yahoo Finance • 4 months ago

Neo Performance Materials Inc. to Present at the Clean Energy Metals Virtual Investor Conference on August 28th

TORONTO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Neo Performance Materials Inc. ("Neo" or the "Company") (TSX: NEO) (OTCQX: NOPMF), based in Toronto, focused on advanced industrial materials, today announced that Jonathan Baksh, Executive Vice... Full story

Yahoo Finance • 4 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO

NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO).  Such investors are advised to contact Danielle Peyton at newac... Full story

Yahoo Finance • 4 months ago

Health care stocks with the largest net increases in hedge fund popularity – Goldman Sachs

[Medical industry stock market graph chart] Rasi Bhadramani Hedge funds increased their overweight positioning in health care (NYSEARCA:XLV [https://seekingalpha.com/symbol/XLV]) despite a 7% decline in the sector during the second quarte... Full story

Yahoo Finance • 5 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO).  Such investors are advised to contact Danielle Peyton at newa... Full story

Yahoo Finance • 5 months ago

Legal AI Software Company Evaluation Report 2025 | LexisNexis, Thomson Reuters, and Wolters Kluwer Lead Legal AI with Innovation, Smart Tools, and Strategic Focus

Dublin, Aug. 06, 2025 (GLOBE NEWSWIRE) -- The "Legal AI Software - Company Evaluation Report, 2025" has been added to ResearchAndMarkets.com's offering. The Legal AI Software Companies Quadrant is a comprehensive industry analysis th... Full story

Yahoo Finance • 5 months ago

Neogenomics stock rating downgraded to Neutral by BTIG on execution concerns

Investing.com - BTIG downgraded Neogenomics (NASDAQ:NEO) from Buy to Neutral on Wednesday, citing concerns about management credibility and product portfolio alignment. The stock, currently trading at $5.25, has declined over 20% in the pa... Full story

Yahoo Finance • 5 months ago

NeoGenomics outlines revised 2025 outlook with 9%-10% revenue growth target amid pharma headwinds and PanTracer launch

Earnings Call Insights: NeoGenomics (NEO) Q2 2025 MANAGEMENT VIEW * CEO Anthony P. Zook stated, "Revenue for Q2 was $181 million, slightly below our second quarter guidance range, though still representing double-digit growth of 10% ye... Full story

Yahoo Finance • 5 months ago

Why Myriad Genetics (MYGN) Shares Are Falling Today

What Happened? Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 3.8% in the afternoon session after weakness in the healthcare sector became pronounced following a poor sales report from a key competitor. The negative... Full story

Yahoo Finance • 5 months ago

NeoGenomics Non-GAAP EPS of $0.03 beats by $0.01, revenue of $181.3M misses by $1.34M

* NeoGenomics press release [https://seekingalpha.com/pr/20180493-neogenomics-reports-second-quarter-2025-results] (NASDAQ:NEO [https://seekingalpha.com/symbol/NEO]): Q2 Non-GAAP EPS of $0.03 beats by $0.01. * Revenue of $181.3M (+10.2... Full story

Yahoo Finance • 5 months ago

NeoGenomics Q2 2025 Earnings Preview

* NeoGenomics (NASDAQ:NEO [https://seekingalpha.com/symbol/NEO]) is scheduled to announce Q2 earnings results on Tuesday, July 29th, before market open. * The consensus EPS Estimate is $0.02 [https://seekingalpha.com/symbol/NEO/earning... Full story